Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Valentin Fuster's new role | Good news for HeartFlow | Transcarotid TAVR | More big stories from the last week
Saturday, October 22, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Cardiologist Valentin Fuster named president of Mount Sinai Heart

The hugely influential doctor will still serve as the general director of the Spanish National Center for Cardiovascular Research and editor-in-chief of the Journal of the American College of Cardiology.

READ MORE >
Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist Valentin Fuster named president of Mount Sinai Heart

Share on Twitter Share on Facebook Share on Linkedin
Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research.
The hugely influential doctor will still serve as the general director of the Spanish National Center for Cardiovascular Research and editor-in-chief of the Journal of the American College of Cardiology.
READ MORE >

HeartFlow gains FDA clearance for 2 new AI-powered imaging assessments

The solutions, Plaque Analysis and RoadMap Analysis, both use coronary CT angiography to provide clinicians with a noninvasive look at patients who present with coronary artery disease and face a heightened myocardial infarction risk.

READ MORE >
Left, HeartFlow's RoadMap analysis enables cardiac CT readers to identify stenoses in the major coronary arteries. The AI provides visualization and quantification of the location and severity of anatomic narrowings. Right image, HeartFlow's Plaque Analysis AI algorithm automates assessment of coronary plaque characteristics and volume on CCTA exams to greatly reduce the time it takes to manually assess and quantify these features.
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow gains FDA clearance for 2 new AI-powered imaging assessments

Share on Twitter Share on Facebook Share on Linkedin
Left, HeartFlow's RoadMap analysis enables cardiac CT readers to identify stenoses in the major coronary arteries. The AI provides visualization and quantification of the location and severity of anatomic narrowings. Right image, HeartFlow's Plaque Analysis AI algorithm automates assessment of coronary plaque characteristics and volume on CCTA exams to greatly reduce the time it takes to manually assess and quantify these features.
The solutions, Plaque Analysis and RoadMap Analysis, both use coronary CT angiography to provide clinicians with a noninvasive look at patients who present with coronary artery disease and face a heightened myocardial infarction risk.
READ MORE >

Leading cardiologists sound the alarm, say polypills could save millions of lives if made widely available

“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” one cardiologist said. 

READ MORE >
older male patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

Leading cardiologists sound the alarm, say polypills could save millions of lives if made widely available

Share on Twitter Share on Facebook Share on Linkedin
older male patient and doctor
“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” one cardiologist said. 
READ MORE >

COVID-19 drug Paxlovid may react poorly with certain heart medications, cardiologists warn

Nirmatrelvir-ritonavir, sold by Pfizer under the name Paxlovid, is commonly prescribed to treat COVID-19. When treating some heart patients, however, physicians may want to consider an alternative approach.

READ MORE >
Doctor patient with masks
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 drug Paxlovid may react poorly with certain heart medications, cardiologists warn

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient with masks
Nirmatrelvir-ritonavir, sold by Pfizer under the name Paxlovid, is commonly prescribed to treat COVID-19. When treating some heart patients, however, physicians may want to consider an alternative approach.
READ MORE >

Transcarotid TAVR a safe alternative when femoral access is not an option

The conventional transfemoral approach is not always possible during TAVR procedures, leaving care teams with an important decision to make. 

READ MORE >
transcarotid TAVR TAVI transcatheter aortic valve replacement
Share on Twitter Share on Facebook Share on Linkedin

Transcarotid TAVR a safe alternative when femoral access is not an option

Share on Twitter Share on Facebook Share on Linkedin
transcarotid TAVR TAVI transcatheter aortic valve replacement
The conventional transfemoral approach is not always possible during TAVR procedures, leaving care teams with an important decision to make. 
READ MORE >

‘He will be deeply missed’: Veteran cardiologist, dead at 76, remembered for his kindness and devotion

Asher Kimchi, MD, a veteran cardiologist with Cedars-Sinai Medical Center in Los Angeles, died on Oct. 7. His friends and colleagues shared loving tributes to his legacy. 

READ MORE >
Asher Kimchi, MD. Image courtesy of Cedars-Sinai.
Share on Twitter Share on Facebook Share on Linkedin

‘He will be deeply missed’: Veteran cardiologist, dead at 76, remembered for his kindness and devotion

Share on Twitter Share on Facebook Share on Linkedin
Asher Kimchi, MD. Image courtesy of Cedars-Sinai.
Asher Kimchi, MD, a veteran cardiologist with Cedars-Sinai Medical Center in Los Angeles, died on Oct. 7. His friends and colleagues shared loving tributes to his legacy. 
READ MORE >

Medtronic cardiac lead the first to receive FDA approval for conduction system pacing

The company’s SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing.

READ MORE >
The Medtronic SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing, providing users with another option when treating patients for bradycardia. According to Medtronic, this marks the first time the FDA has approved a device for this indication.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic cardiac lead the first to receive FDA approval for conduction system pacing

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing, providing users with another option when treating patients for bradycardia. According to Medtronic, this marks the first time the FDA has approved a device for this indication.
The company’s SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme